A snapshot of protein trafficking in SARS‐CoV‐2 infection
暂无分享,去创建一个
[1] S. Whelan,et al. SARS-CoV-2 requires acidic pH to infect cells , 2022, bioRxiv.
[2] L. Giaquinto,et al. The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle , 2022, Nature.
[3] M. Merad,et al. The immunology and immunopathology of COVID-19 , 2022, Science.
[4] F. Reggiori,et al. Molecular regulation of autophagosome formation , 2022, Biochemical Society transactions.
[5] J. Qi,et al. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry , 2022, Proceedings of the National Academy of Sciences.
[6] Ran Gao,et al. SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages , 2022, Cellular & molecular immunology.
[7] Hangtian Guo,et al. Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1–Nup98 Complex to Compete With mRNA Nuclear Export , 2022, Frontiers in Molecular Biosciences.
[8] S. Srikanth,et al. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling. , 2021, Journal of immunology.
[9] R. Bartenschlager,et al. Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation , 2021, Cell Reports.
[10] D. Voon,et al. NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells , 2021, Biochemical and Biophysical Research Communications.
[11] Steven B. Bradfute,et al. Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes , 2021, Cell.
[12] Guðjón Ólafsson,et al. Forced association of SARS-CoV-2 proteins with the yeast proteome perturb vesicle trafficking , 2021, Microbial cell.
[13] Aijun Wang,et al. Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy , 2021, Advanced materials.
[14] M. Farzan,et al. Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.
[15] Tao Wang,et al. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases , 2021, bioRxiv.
[16] P. Bieniasz,et al. VPS29 Exerts Opposing Effects on Endocytic Viral Entry , 2021, bioRxiv.
[17] E. Holmes,et al. The origins of SARS-CoV-2: A critical review , 2021, Cell.
[18] Kyoko Furuita,et al. Sequence requirements of the FFAT‐like motif for specific binding to VAP‐A are revealed by NMR , 2021, FEBS letters.
[19] M. Malim,et al. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction , 2021, bioRxiv.
[20] P. A. Friedman,et al. ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion , 2021, iScience.
[21] Guoyu Yang,et al. NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry , 2021, Science China Life Sciences.
[22] H. Erfle,et al. Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation , 2021, Nature Communications.
[23] Yong Lin,et al. The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes , 2021, Cell Discovery.
[24] J. Yue,et al. Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2 , 2021, Signal Transduction and Targeted Therapy.
[25] M. Gale,et al. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98 , 2021, mBio.
[26] R. Holmdahl,et al. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification , 2021, Computational and Structural Biotechnology Journal.
[27] Xiao Li,et al. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice , 2021, Virology journal.
[28] J. Minna,et al. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression , 2021, Science Advances.
[29] M. Seaman. The Retromer Complex: From Genesis to Revelations. , 2021, Trends in biochemical sciences.
[30] S. Badawi,et al. ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues , 2020, Human Genomics.
[31] Silva Kasela,et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells , 2020, Cell.
[32] G. Whittaker,et al. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin , 2021, ACS infectious diseases.
[33] M. Mann,et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV , 2020, Nature.
[34] Y. Bi,et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation , 2020, Developmental Cell.
[35] M. Hazawa,et al. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex , 2020, Biochemical and Biophysical Research Communications.
[36] E. Kudryashova,et al. Opposing activities of IFITM proteins in SARS‐CoV‐2 infection , 2020, The EMBO journal.
[37] R. Friesner,et al. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains , 2020, Cell Host & Microbe.
[38] R. Bartenschlager,et al. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies , 2020, Cell Host & Microbe.
[39] V. Thiel,et al. Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.
[40] G. Altan-Bonnet,et al. β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway , 2020, Cell.
[41] A. Helenius,et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.
[42] M. Guttman,et al. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses , 2020, Cell.
[43] Zhènglì Shí,et al. Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.
[44] Vineet D. Menachery,et al. Evasion of Type I Interferon by SARS-CoV-2 , 2020, Cell Reports.
[45] Xiaosheng Wang,et al. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses , 2020, Frontiers in Immunology.
[46] K. To,et al. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2 , 2020, Nature Communications.
[47] L. Ren,et al. Activation and evasion of type I interferon responses by SARS-CoV-2 , 2020, Nature Communications.
[48] D. A. Stein,et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells , 2020, Life Science Alliance.
[49] C. Rice,et al. LY6E impairs coronavirus fusion and confers immune control of viral disease , 2020, Nature Microbiology.
[50] M. Farzan,et al. Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 , 2020, bioRxiv.
[51] J. Skehel,et al. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects , 2020, Nature Structural & Molecular Biology.
[52] L. Martin-Jaular,et al. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS‐CoV‐2 Spike protein‐containing virus , 2020, bioRxiv.
[53] Wuyuan Lu,et al. Interferon-Induced Transmembrane Protein 3 Blocks Fusion of Diverse Enveloped Viruses by Locally Altering Mechanical Properties of Cell Membranes , 2020, bioRxiv.
[54] D. Agard,et al. A molecular pore spans the double membrane of the coronavirus replication organelle , 2020, Science.
[55] Tiago J. S. Lopes,et al. Identification of interferon-stimulated genes that attenuate Ebola virus infection , 2020, Nature Communications.
[56] D. Fremont,et al. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion , 2020, Proceedings of the National Academy of Sciences.
[57] A. Helenius,et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system , 2020, bioRxiv.
[58] D. Matthews,et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection , 2020, Science.
[59] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[60] D. A. Stein,et al. TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets , 2020, bioRxiv.
[61] K. Yuen,et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.
[62] Yan Liu,et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.
[63] Abraham J. Koster,et al. A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis , 2020, bioRxiv.
[64] Tony Y. Hu,et al. Insights from nanomedicine into chloroquine efficacy against COVID-19 , 2020, Nature Nanotechnology.
[65] K. Shi,et al. Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.
[66] C. Rice,et al. LY6E impairs coronavirus fusion and confers immune control of viral disease , 2020, Nature Microbiology.
[67] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[68] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[69] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[70] S. Ludwig,et al. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine , 2020, bioRxiv.
[71] W. Prinz,et al. The functional universe of membrane contact sites , 2019, Nature Reviews Molecular Cell Biology.
[72] J. Sluijter,et al. Interfering with endolysosomal trafficking enhances release of bioactive exosomes. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[73] T. Yoshimori,et al. Distinct functions of ATG16L1 isoforms in membrane binding and LC3B lipidation in autophagy-related processes , 2019, Nature Cell Biology.
[74] S. Pfeffer,et al. NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes , 2019, The Journal of Biological Chemistry.
[75] C. Viret,et al. Regulation of Syntaxin 17 during Autophagosome Maturation. , 2019, Trends in cell biology.
[76] Nicholas Rinkenberger,et al. LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step , 2018, Nature Communications.
[77] Traci L. Marin,et al. AMP‐activated Protein Kinase Phosphorylation of Angiotensin‐Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension , 2018, American journal of respiratory and critical care medicine.
[78] S. Cherry,et al. Flavivirus internalization is regulated by a size-dependent endocytic pathway , 2018, Proceedings of the National Academy of Sciences.
[79] Huaxi Xu,et al. The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases , 2018, Front. Aging Neurosci..
[80] N. Gao,et al. A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3 , 2018, Cell Death & Disease.
[81] A. Koster,et al. Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication , 2017, mBio.
[82] O. Schwartz,et al. IFITM3 requires an amphipathic helix for antiviral activity , 2017, EMBO reports.
[83] P. D. Nagy,et al. Building Viral Replication Organelles: Close Encounters of the Membrane Types , 2016, PLoS pathogens.
[84] T. Levine,et al. VAP, a Versatile Access Point for the Endoplasmic Reticulum: Review and analysis of FFAT-like motifs in the VAPome. , 2016, Biochimica et biophysica acta.
[85] T. Rapoport,et al. Cooperation of the ER-shaping proteins atlastin, lunapark, and reticulons to generate a tubular membrane network , 2016, eLife.
[86] Yohei Yamauchi,et al. Principles of Virus Uncoating: Cues and the Snooker Ball , 2016, Traffic.
[87] F. V. van Kuppeveld,et al. Fat(al) attraction: Picornaviruses Usurp Lipid Transfer at Membrane Contact Sites to Create Replication Organelles , 2016, Trends in Microbiology.
[88] G. Voeltz,et al. Structure and function of ER membrane contact sites with other organelles , 2015, Nature Reviews Molecular Cell Biology.
[89] Yves Renaudineau,et al. Calcium signaling and cell fate: how can Ca2+ signals contribute to wrong decisions for Chronic Lymphocytic Leukemic B lymphocyte outcome? , 2015, The International journal of developmental biology.
[90] Ru-jing Ren,et al. The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration , 2015, Translational Neurodegeneration.
[91] Charles M. Rice,et al. Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response , 2015, Nature.
[92] R. Bartenschlager,et al. Hepatitis C Virus RNA Replication and Assembly: Living on the Fat of the Land , 2014, Cell Host & Microbe.
[93] F. Torta,et al. Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. , 2014, Cell host & microbe.
[94] R. Teasdale,et al. A unique PDZ domain and arrestin-like fold interaction reveals mechanistic details of endocytic recycling by SNX27-retromer , 2014, Proceedings of the National Academy of Sciences.
[95] Xin Zhang,et al. Signal recognition particle: an essential protein-targeting machine. , 2013, Annual review of biochemistry.
[96] Y. Yamauchi,et al. Virus entry at a glance , 2013, Journal of Cell Science.
[97] G. Cheng,et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. , 2013, Immunity.
[98] E. Gratton,et al. IFITM Proteins Restrict Viral Membrane Hemifusion , 2013, PLoS pathogens.
[99] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.
[100] G. Whittaker,et al. Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein , 2012, Viruses.
[101] D. Rubinsztein,et al. Autophagosome Precursor Maturation Requires Homotypic Fusion , 2011, Cell.
[102] Karl H. Wolf,et al. Comparative review , 2011, J. Documentation.
[103] C. Rice,et al. Suppression of inflammation by a synthetic histone mimic , 2010, Nature.
[104] D. Rubinsztein,et al. Plasma membrane helps autophagosomes grow , 2010, Autophagy.
[105] M. Stewart. Nuclear export of mRNA. , 2010, Trends in biochemical sciences.
[106] G. Charron,et al. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. , 2010, Nature chemical biology.
[107] E. Ruoslahti,et al. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration , 2009, Proceedings of the National Academy of Sciences.
[108] L. Gakhar,et al. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[109] S. R. Wente,et al. mRNA nuclear export at a glance , 2009, Journal of Cell Science.
[110] Ralph S. Baric,et al. Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane , 2007, Journal of Virology.
[111] R. Weinstein. Planning for epidemics--the lessons of SARS. , 2004, The New England journal of medicine.
[112] D. Dimitrov,et al. Virus entry: molecular mechanisms and biomedical applications , 2004, Nature Reviews Microbiology.
[113] A. Cassone,et al. Effects of chloroquine on viral infections: an old drug against today's diseases , 2003, The Lancet Infectious Diseases.
[114] Kevin Struhl,et al. TREX is a conserved complex coupling transcription with messenger RNA export , 2002, Nature.
[115] B. Séraphin,et al. A U1 snRNA:pre‐mRNA base pairing interaction is required early in yeast spliceosome assembly but does not uniquely define the 5′ cleavage site. , 1988, The EMBO journal.